Qian Chu
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- COVID-19 and healthcare impacts
- Cancer Cells and Metastasis
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
Papers in
- Oncology 110
- Cancer Immunotherapy and Biomarkers 48
- Lung Cancer Research Studies 21
- Colorectal Cancer Treatments and Studies 11
-
- Lung Cancer Treatments and Mutations 41
- Lung Cancer Diagnosis and Treatment 17
Qian Chu
189 papers receiving 8.3k citations
Hit Papers
Peers
Comparison fields: 5 of 173
- Oncology 3.7k
- Cancer Research 1.2k
- Immunology 1.6k
- Molecular Biology 3.4k
- Infectious Diseases 853
Countries citing papers authored by Qian Chu
This map shows the geographic impact of Qian Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qian Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qian Chu more than expected).
Fields of papers citing papers by Qian Chu
This network shows the impact of papers produced by Qian Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qian Chu. The network helps show where Qian Chu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qian Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 8 | |
| 9 | 2024 | 4 | |
| 10 | 2024 | 12 | |
| 11 | 2024 | 3 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 15 | |
| 14 | 2023 | 10 | |
| 15 | 2023 | 40 | |
| 16 | 2021 | 54 | |
| 17 | Production, bioactive properties, and potential applications of fish protein hydrolysates: Developments and challenges Hit paper breakdown → | 2021 | 178 |
| 18 | 2020 | 11 | |
| 19 | 2013 | 39 | |
| 20 | 2006 | 45 |
About Qian Chu
Qian Chu is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 205 papers that have together received 8.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (48 papers), Lung Cancer Treatments and Mutations (41 papers), Lung Cancer Research Studies (21 papers), Lung Cancer Diagnosis and Treatment (17 papers), Immunotherapy and Immune Responses (12 papers), Colorectal Cancer Treatments and Studies (11 papers), Radiomics and Machine Learning in Medical Imaging (11 papers) and Immune cells in cancer (10 papers). The work is most often cited by research in Oncology (3.7k citations), Cancer Research (1.2k citations), Immunology (1.6k citations), Molecular Biology (3.4k citations) and Infectious Diseases (853 citations). Qian Chu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Kongming Wu, Ming Yi, Shuang Qin, Anping Li, Xun Yuan, Hanxiao Xu, Dechao Jiao, Shiying Yu, Yunkai Yang and Weiheng Zhao. Their work appears in journals such as Journal of Hematology & Oncology, Journal of Clinical Oncology, Experimental Hematology and Oncology, Annals of Oncology and Translational Lung Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.